𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Colony stimulating factor for bone marrow transplantation

✍ Scribed by T. Masaoka; K. Motoyoshi; F. Takaku; S. Kato; M. Harada; Y. Kodera; A. Kanamaru; R. Ohno; T. Inoue


Publisher
Elsevier Science
Year
1988
Tongue
English
Weight
81 KB
Volume
10
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Recombinant human granulocyte colony-sti
✍ Takahashi, Satoshi; Oshima, Yasuo; Okamoto, Shin-ichiro; Nishiwaki, Kaichi; Naga πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 1 views

We previously suggested that using a combined conditioning regimen including rhG-CSF with allogeneic BMT in refractory AML and CML in blast crisis might reduce the rate of relapse and improve disease-free survival, without any major side effects. In this study, we used the same protocol for 10 AML p

Tissue sources of bone marrow colony sti
✍ J. W. Sheridan; E. R. Stanley πŸ“‚ Article πŸ“… 1971 πŸ› John Wiley and Sons 🌐 English βš– 618 KB

Possible tissue sources in C57BL mice of the serum factor stimulating colony formation in vitro by mouse bone marrow cells have been investigated. A reproducible technique employing batch chromatography on calcium phosphate gel was developed for the extraction and assay of material with colony stim

Granulocyte-colony-stimulating factor af
✍ Saarinen, Ulla M. ;Hovi, Liisa ;Juvonen, Eeva ;Riikonen, Pekka ;MΓΆttΓΆnen, Merja πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 685 KB

We evaluated the use of granulocyte CSF (G-CSF) after both allogeneic BMT (allo-BMT) and autologous BMT (ABMT) in children. After allo-BMT, G-CSF was used in 15 children who were compared with 20 historical controls. The ABMT patients were two sequential groups: the G-CSF group of 13 children and 11

The use of colony stimulating factors in
✍ Robert S Negrin; Peter L Greenberg πŸ“‚ Article πŸ“… 1992 πŸ› Elsevier Science 🌐 English βš– 508 KB

The use of colony stimulating factors in clinical bone marrow transplantation is rapidly evolving. Both granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor have shown efficacy in bone marrow transplant patients in accelerating the rate of myeloid recovery. The